湖岸生物上涨19.17%，报0.9美元/股，总市值3709.14万美元

Group 1 - The stock price of Lakeshore Biosciences (LSB) increased by 19.17% on August 1, reaching $0.90 per share, with a trading volume of $43,400 and a total market capitalization of $37.09 million [1] - As of September 30, 2024, Lakeshore Biosciences reported total revenue of 372 million RMB, representing a year-on-year growth of 36.2% [1] - The net profit attributable to the parent company was 20.58 million RMB, showing a significant year-on-year increase of 111.79% [1] Group 2 - Lakeshore Biosciences is a Cayman Islands-registered holding company primarily operated by its domestic subsidiary, Beijing Yisheng Biotechnology Co., Ltd. [1] - Beijing Yisheng Biotechnology Co., Ltd. is a global biopharmaceutical company focused on the discovery, development, production, and commercialization of next-generation vaccines and therapeutic biologics for infectious diseases and cancer [1]